Photodynamic therapy in head and neck oncology;Thérapie photodynamique en cancérologie cervico-faciale

Revue Medicale de Bruxelles

Volumn 29, Issue 1, 2008, Pages 23-25

  Dequanter, D ^a,d   Lothaire, P ^a   Meert, A P ^b   Andry, G ^c  

^a C H U de Charleroi

^b Centre Hospitalier Régional du Val de Sambre Rue Chère Voie   (Belgium)

^c JULES BORDET INSTITUTE   (Belgium)

^d CHU de Charleroi   (France)

Author keywords

Head and neck cancer; Palliative treatment; Photodynamic therapy

Indexed keywords

PHOTOSENSITIZING AGENT; TEMOPORFIN;

ADVANCED CANCER; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; HEAD CANCER; NECK CANCER; PALLIATIVE THERAPY; PHOTODYNAMIC THERAPY; REVIEW; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 41549150788     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Ansell JK, De Jode ML, Grahn MF : Characaterization of a murine model for the rapid assessment of acute photodynamic response in tumour and muscle. Laser Med Sci 1997 ; 12 : 336-41
2. Blant SA, Woodtli A, Wagnières G : In vivo fluence rate effect in photodynamic therzpy of early cancers with tretra(m-hydroxyphenyl) chlorin. Photochem Photobiol 1996 ; 64 : 963-8
3. Ma L, Moan J, Berg K : Evaluation of a new photosensitizer, meso tetra hydroxypheylchlorin for use in photodynamic therapy : a comparison of its photobiological properties with those of two other photosensitizers. Int J Cancer 1994 ; 57 : 883-8
4. Andrejevic-Blant SA, Hadjur CH, Ballini J-P : Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin : optimal drug-light interval Br J Cancer 1997 ; 76 : 1021-8
5. Lofgren LA, Ronn AM, Abramson AL : Photodynamic therapy using m-tetra(hydroxyphenyl)chlorin. An animal model. Arch Otolaryngol Head Neck Surg 1994 ; 120 : 1355-62
6. Ris H-B, Li Q, Krueger T : Photosensitizing effects of m-tetrahudroxyphenylchlorin on human tumor xenografts : correlation with sensitizer uptake, tumor doubling time and tumor histology. Int J Cancer 1998 ; 76 : 872-4
7. Biel MA : Photodynamic therapy using Photofrin and Foscan and the treatment of malignancies of the head and neck. Proc SPIE-Int Soc opt Eng 1998 ; 3247 : 25-30
8. Lou PJ, Jäger HR, Jones L, Theodossy T, Bown SG, Hopper C : Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br J Cancer 2004 ; 91 : 441-6
9. D'Cruz A, Robinson MH, Biel MA : mTHPC-mediated photodynamic therapy in patients with advanced incurable head and neck cancer : a multicenter study of 128 patients. Head Neck 2004 ; 26 : 232-40
10. Tan IB : Foscan- mediated photodynamic therapy in recurrent and second primary oral cavity cancers. Laryngo-Rhino-Otology 2000 ; 79 : 318
11. Wenig BL, D'Cruz A, Iqbal A, Bryce RP : Foscan mediated photodynamic therapy in the palliative treatment of advanced head and neck cancer. Proc Am Soc Clin Oncol 2000 ; 19 : abstract 1652
12. Hopper C, Niziol C, Sidhu M : The cost-effectiveness of Foscan mediated photodynamic therapy compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK. Oral Oncology 2004 ; 40 : 372-82